A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)
Clinical trial NCT05879744 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05879744
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2026-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.